Kagabu Masahiro 利部正裕

Researcher Number	30382609
Other IDs	https://orcid.org/0000-0003-0926-1015
Affiliation (Current)	2024: 岩手医科大学, 医学部, 特任准教授
Affiliation (based on the past Project Information) *help	2023 – 2024: 岩手医科大学, 医学部, 特任准教授 2020 – 2022: 岩手医科大学, 医学部, 講師 2018 – 2019: 岩手医科大学, 医学部, 特任講師 2016 – 2017: 岩手医科大学, 医学部, 講師
Review Section/Research Field	Principal Investigator Basic Section 56040:Obstetrics and gynecology-related / Obstetrics and gynecology Except Principal Investigator Basic Section 56040:Obstetrics and gynecology-related / Obstetrics and gynecology
Keywords	Principal Investigator 腫瘍浸潤リンパ球 / 腫瘍溶解性ヘルペスウイルス / 腫瘍免疫 / 腫瘍溶解性ウイルス / 子宮癌肉腫 / ウイルス療法 / 腫瘍免疫学 / 婦人科腫瘍学 / T細胞共刺激分子 / 子宮頸がん … More / 卵巣がん / 免疫チェックポイント阻害薬 / 子宮頸癌 / 卵巣癌 … More Except Principal Investigator 卵巣癌 / 明細胞癌 / 子宮体癌 / バイオマーカー / 卵巣明細胞癌 / HSP / p53abn / MDSC / リンパ球 / 腫瘍微小環境 / マウスモデル / 局所免疫 / 漿液性癌 / NEFH / 治療標的 / KANK1 / 卵巣がん / シスプラチン / Aurora kinase A Less

Integrating precision medicine for p53abn endometrial cancer
- Principal Investigator
  
  馬場長
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Iwate Medical University
卵巣明細胞癌に対するＨＳＦ１経路を標的とした新規治療法の開発
- Principal Investigator
  
  板持広明
- Project Period (FY)
  2023 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Iwate Medical University
子宮癌肉腫に対する免疫逃避改善を誘導するウイルス療法の開発Principal Investigator
- Principal Investigator
  
  利部正裕
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Iwate Medical University
Development of tumor-host integrative therapies to overcome the refractory nature of uterine serous carcinoma
- Principal Investigator
  
  Baba Tsukasa
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Iwate Medical University
The NEFH pathway may be a novel therapeutic target for ovarian clear cell carcinoma
- Principal Investigator
  
  ITAMOCHI Hiroaki
- Project Period (FY)
  2019 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Iwate Medical University
The KANK1 pathway may be a novel therapeutic target for ovarian clear cell carcinoma
- Principal Investigator
  
  ITAMOCHI Hiroaki
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Iwate Medical University
Development of new viral therapy for improvement of immune escape mechanism in ovarian cancerPrincipal Investigator
- Principal Investigator
  
  Kagabu Masahiro
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Challenging Exploratory Research
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Iwate Medical University

All 2024 2023 2022 2021 2018 2017 2016

All Journal Article Presentation

[Journal Article] A single-institution retrospective exploratory analysis on the effectiveness and safety of lenvatinib plus pembrolizumab for advanced endometrial cancer: insights from ProMisE molecular classification system2024
- Author(s)
  Chiba Yohei、Kagabu Masahiro、Osakabe Mitsumasa、Ito Rikako、Sato Sho、Takatori Eriko、Kaido Yoshitaka、Nagasawa Takayuki、Shoji Tadahiro、Yanagawa Naoki、Baba Tsukasa
- Journal Title
  
  Japanese Journal of Clinical Oncology
  
  Volume: 54 Issue: 4 Pages: 424-433
- DOI
  10.1093/jjco/hyad192
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21K09548
[Journal Article] SLFN11 is a <i>BRCA</i> Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma2023
- Author(s)
  Akashi Hidehiko、Yachida Nozomi、Ueda Haruka、Yamaguchi Manako、Yamawaki Kaoru、Tamura Ryo、Suda Kazuaki、Ishiguro Tatsuya、Adachi Sosuke、Nagase Yoshikazu、Ueda Yutaka、Ueda Masashi、Abiko Kaoru、Kagabu Masahiro、Baba Tsukasa、Nakaoka Hirofumi、Enomoto Takayuki、Murai Junko、Yoshihara Kosuke
- Journal Title
  
  Molecular Cancer Therapeutics
  
  Volume: 23 Issue: 1 Pages: 106-116
- DOI
  10.1158/1535-7163.mct-23-0257
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K16431, KAKENHI-PROJECT-22K09635, KAKENHI-PROJECT-23K08794, KAKENHI-PROJECT-23K08859, KAKENHI-PROJECT-21K09548, KAKENHI-PROJECT-21K16810, KAKENHI-PROJECT-22H04925, KAKENHI-PROJECT-23K27447, KAKENHI-PROJECT-23K27459
[Journal Article] Ovarian serous borderline tumors with recurrent or extraovarian lesions: a Japanese, retrospective, multi-institutional, population-based study2023
- Author(s)
  Baba Tsukasa、Koshiyama Masafumi、Kagabu Masahiro、Mikami Yoshiki、Minamiguchi Sachiko、Moritani Suzuko、Ishikawa Mitsuya、Okamoto Aikou、Terao Yasuhisa、Nakanishi Toru、Katabuchi Hidetaka、Tokunaga Hideki、Satoh Toyomi、Konishi Ikuo、Yaegashi Nobuo
- Journal Title
  
  International Journal of Clinical Oncology
  
  Volume: 28 Issue: 10 Pages: 1411-1420
- DOI
  10.1007/s10147-023-02393-z
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21K09548
[Journal Article] A Phase II Study of S-1 plus Oxaliplatin for Patients with Recurrent Non-Squamous Cell Carcinoma of the Uterine Cervix (Tohoku Gynecologic Cancer Unit: TGCU206 Study)2023
- Author(s)
  Nagasawa Takayuki、Shoji Tadahiro、Takatori Eriko、Kaido Yoshitaka、Kagabu Masahiro、Shimizu Dai、Shigeto Tatsuhiko、Baba Tsukasa、Sugiyama Toru、Yokoyama Yoshihito
- Journal Title
  
  Cancers
  
  Volume: 15 Issue: 21 Pages: 5201-5201
- DOI
  10.3390/cancers15215201
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21K09548
[Journal Article] Efficacy and Safety of Platinum-based Chemotherapy with Bevacizumab Followed by Bevacizumab Maintenance for Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer During PARP Inhibitor Therapy: A Multicenter Retrospective Study.2023
- Author(s)
  Abe M, Shoji T, Chiba Y, Takatori E, Kaido Y, Nagasawa T, Kagabu M, Takahashi F, Aida T, Baba T.
- Journal Title
  
  Anticancer Res
  
  Volume: 43(3) Issue: 3 Pages: 1265-1272
- DOI
  10.21873/anticanres.16273
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21K09548
[Journal Article] Treatment of HPV-related uterine cervical cancer with a third-generation oncolytic herpes simplex virus in combination with an immune checkpoint inhibitor.2023
- Author(s)
  Kagabu M, Yoshino N, Murakami K, Kawamura H, Sasaki Y, Muraki Y, Baba T.
- Journal Title
  
  Int J Mol Sci.
  
  Volume: 24(3) Issue: 3 Pages: 1988-1988
- DOI
  10.3390/ijms24031988
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K08511, KAKENHI-PROJECT-21K09548, KAKENHI-PROJECT-22K09602
[Journal Article] Comparison of treatment outcomes between first-line chemotherapy with or without bevacizumab for advanced ovarian, fallopian tube, and primary peritoneal cancer (Tohoku gynecologic cancer unit: TGCU-RS001 study)2022
- Author(s)
  Takatori E, Nagasawa T, Kagabu M, Baba T, Shigeto T, Matsumura Y, Shimizu D, Terada Y, Seino M, Ohta T, Nagase S, Shigeta S, Tokunaga H, Shimada M, Kaiho-Sakuma M, Furukawa S, Soeda S, Watanabe T, Takahashi F, Yokoyama Y.
- Journal Title
  
  International Journal of Clinical Oncology
  
  Volume: 27 Issue: 12 Pages: 1874-1880
- DOI
  10.1007/s10147-022-02246-1
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K09531, KAKENHI-PROJECT-21K09548
[Journal Article] Sentinel node navigation surgery in cervical cancer: a systematic review and metaanalysis.2022
- Author(s)
  Chiyoda T, Yoshihara K, Kagabu M, Nagase S, Katabuchi H, Mikami M, Tabata T, Hirashima Y, Kobayashi Y, Kaneuchi M, Tokunaga H, Baba T
- Journal Title
  
  Int J Clin Oncol.
  
  Volume: 27(8) Issue: 8 Pages: 1247-1255
- DOI
  10.1007/s10147-022-02178-w
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K09548, KAKENHI-PROJECT-22K09635, KAKENHI-PROJECT-22H04923
[Journal Article] Efficacy and Safety of Platinum Rechallenge in Patients With Platinum-resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer: A Multicenter Retrospective Study.2022
- Author(s)
  Tatsuki S, Shoji T, Abe M, Tomabechi H, Takatori E, Kaido Y, Nagasawa T, Kagabu M, Aida T, Baba T.
- Journal Title
  
  Anticancer Res.
  
  Volume: 42(9) Issue: 9 Pages: 4603-4610
- DOI
  10.21873/anticanres.15964
- Data Source
  KAKENHI-PROJECT-21K09548
[Journal Article] Immunosuppressive tumor microenvironment in Uterine Serous Carcinoma via CCL7 signal with myeloid-derived suppressor cells.2022
- Author(s)
  Mise Y, Hamanishi J, Daikoku T, Takamatsu S, Miyamoto T, Taki M, Yamanoi K, Yamaguchi K, Ukita M, Horikawa N, Abiko K, Murakami R, Furutake Y, Hosoe Y, Terakawa J, Kagabu M, Sugai T, Osakabe M, Fujiwara H, Matsumura N, Mandai M, Baba T.
- Journal Title
  
  Carcinogenesis
  
  Volume: na Issue: 7 Pages: 647-658
- DOI
  10.1093/carcin/bgac032
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K09287, KAKENHI-PROJECT-18H02947, KAKENHI-PROJECT-21K09548, KAKENHI-PROJECT-20K16431, KAKENHI-PROJECT-21K09512, KAKENHI-PROJECT-21J15178, KAKENHI-PROJECT-20K07412
[Journal Article] Novel therapeutic strategies for refractory ovarian cancers: Clear cell and mucinous carcinomas.2021
- Author(s)
  Shoji T, Tatsuki S, Abe M, Tomabechi H, Takatori E, Kaido Y, Nagasawa T, Kagabu M, Baba T, Itamochi H.
- Journal Title
  
  Cancers
  
  Volume: 13 Issue: 23 Pages: 6120-6120
- DOI
  10.3390/cancers13236120
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K09759
[Journal Article] Comparison of Postoperative Adjuvant Chemotherapy and Concurrent Chemoradiotherapy for FIGO2018 Stage IIIC1 Cervical Cancer: A Retrospective Study2021
- Author(s)
  Kagabu Masahiro、Nagasawa Takayuki、Tatsuki Shunsuke、Fukagawa Yasuko、Tomabechi Hidetoshi、Takatori Eriko、Kaido Yoshitaka、Shoji Tadahiro、Baba Tsukasa
- Journal Title
  
  Medicina
  
  Volume: 57 Issue: 6 Pages: 548-548
- DOI
  10.3390/medicina57060548
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K09548
[Journal Article] Mast cells partially contribute to mucosal adjuvanticity of surfactin in mice.2018
- Author(s)
  Yoshino N, Takeshita R, Kawamura H, Sasaki Y, Kagabu M, Sugiyama T, Muraki Y, Sato S.
- Journal Title
  
  Immun Inflamm Dis.
  
  Volume: 6 Issue: 1 Pages: 117-127
- DOI
  10.1002/iid3.204
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K15711
[Journal Article] Critical micelle concentration and particle size determine adjuvanticity of cyclic lipopeptides2018
- Author(s)
  Yoshino N, Takeshita R, Kawamura H, Murakami K, Sasaki Y, Sugiyama I, Sadzuka Y, Kagabu M, Sugiyama T, Muraki Y, Sato S.
- Journal Title
  
  Scandinavian Journal of Immunology
  
  Volume: 88 Issue: 2
- DOI
  10.1111/sji.12698
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K08445, KAKENHI-PROJECT-16K15711
[Journal Article] The efficacy of oncolytic herpes simplex viral therapy for uterine cervical cancer2018
- Author(s)
  Masahiro Kagabu, Naoto Yoshino, Tatsunori Saito, Yuki Miura, Ryosuke Takeshita, Kazuyuki Murakami, Hideki Kawamura, Tsukasa Baba, Toru Sugiyama
- Journal Title
  
  OncoTargets and Therapy(under review)
  
  Volume: -
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K15711
[Journal Article] 腫瘍溶解性ヘルペスウイルスとシクロホスファミドを併用した子宮頸がん新規治療法の検討2017
- Author(s)
  川村　英生，利部　正裕，佐々木　裕，村上　一行，川村　花恵，池田　浩，阿保　亜希子，吉野　直人，村木　靖，杉山　徹
- Journal Title
  
  岩手医学会雑誌
  
  Volume: 69
- NAID
  40021252419
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-16K15711
[Journal Article] 腫瘍溶解性ヘルペスウイルスとシクロホスファミドを併用した子宮頸がん新規治療法の検討2017
- Author(s)
  川村英生，利部正裕，佐々木裕，村上一行，川村花恵，池田浩，阿保亜希子，吉野直人，村木靖，杉山徹
- Journal Title
  
  岩手医学会雑誌
  
  Volume: 69 Pages: 75-88
- NAID
  40021252419
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K15711
[Journal Article] 腫瘍溶解性ウイルスと免疫チェックポイント阻害剤を併用した子宮頸がんに対する新規治療法の検討2016
- Author(s)
  村上　一行，利部　正裕，佐々木　裕，川村　花恵，川村　英生，吉野　直人，村木　靖，杉山　徹
- Journal Title
  
  岩手医学会雑誌
  
  Volume: 68 Pages: 113-130
- NAID
  40020971476
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-16K15711
[Presentation] Efficacy of combination chemotherapy and third-generation oncolytic herpes virus therapy for Cervical Cancer2023
- Author(s)
  Masahiro Kagabu, Hideki Kawamura, Kazuyuki Murakami, Hanae Kawamura, Naoto Yoshino, Yasushi Muraki and Tsukasa Baba
- Organizer
  International Gynecologic Cancer Society Annual Global Meeting 2023
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K09602
[Presentation] 子宮頸がん検診によって発見された子宮頸部腺癌の検討2018
- Author(s)
  利部正裕
- Organizer
  日本臨床細胞学会総会
- Data Source
  KAKENHI-PROJECT-16K15711
[Presentation] 癌治療におけるCART 婦人科悪性腫瘍患者におけるCART療法2018
- Author(s)
  利部正裕
- Organizer
  日本アフェレシス学会学術講演会
- Data Source
  KAKENHI-PROJECT-16K15711
[Presentation] 子宮頸がんに対する腫瘍溶解性ウイルスと免疫チェックポイント阻害剤を併用した新規療法の検討2017
- Author(s)
  村上　一行，利部　正裕，佐々木　裕，川村　花恵，川村　英生，吉野　直人，村木　靖，杉山　徹
- Organizer
  第34回日本産婦人科感染症学会・学術集会
- Place of Presentation
  奈良春日野国際フォーラム（奈良）
- Year and Date
  2017-05-20
- Data Source
  KAKENHI-PROJECT-16K15711
[Presentation] 子宮頸がんに対する腫瘍溶解性ウイルスと免疫チェックポイント阻害剤を併用した新規療法の検討2017
- Author(s)
  村上一行，利部正裕，佐々木裕，川村花恵，川村英生，吉野直人，村木靖，杉山徹
- Organizer
  第34回日本産婦人科感染症学会・学術集会
- Data Source
  KAKENHI-PROJECT-16K15711
[Presentation] 子宮頸がんに対する化学療法とウイルス併用療法への基礎研究2017
- Author(s)
  川村英生, 利部正裕, 村上一行, 川村花恵, 板持広明, 杉山徹
- Organizer
  第68回日本産科婦人科学会総会・学術講演会
- Data Source
  KAKENHI-PROJECT-16K15711
[Presentation] 腫瘍溶解性ウイルスと化学療法を併用した子宮頸がん新規治療法の検討2017
- Author(s)
  川村英生，利部正裕，佐々木裕，村上一行，川村花恵，池田浩，阿保亜希子，吉野直人，村木靖，杉山徹
- Organizer
  第34回日本産婦人科感染症学会・学術集会
- Data Source
  KAKENHI-PROJECT-16K15711
[Presentation] Aurora-A inhibition synergistically enhances cisplatin induced cytotoxicity in ovarian clear cell carcinoma cell lines.2017
- Author(s)
  Chiba Y, Sato S, Fukagawa D, Suga Y, Kagabu M, Chiba A, Takeuchi S, Itamochi H, Sugai T, Sugiyama T.
- Organizer
  5th Biennial Meeting of Asian Society of Gynecologic Oncology
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K11151
[Presentation] 腫瘍溶解性ウイルスと化学療法を併用した子宮頸がん新規治療法の検討2017
- Author(s)
  川村　英生，利部　正裕，佐々木　裕，村上　一行，川村　花恵，池田　浩，阿保　亜希子，吉野　直人，村木　靖，杉山　徹
- Organizer
  第34回日本産婦人科感染症学会・学術集会
- Place of Presentation
  奈良春日野国際フォーラム（奈良）
- Year and Date
  2017-05-20
- Data Source
  KAKENHI-PROJECT-16K15711
[Presentation] 子宮頸がんに対する単純ヘルペスウイルスを用いたウイルス療法と抗がん剤併用療法における基礎研究2016
- Author(s)
  川村英生, 利部正裕, 村上一行, 佐々木裕, 川村花恵, 吉野直人, 村木靖, 杉山徹
- Organizer
  第64回北日本産科婦人科学会総会・学術講演会
- Place of Presentation
  ロイトン札幌（札幌）
- Year and Date
  2016-09-17
- Data Source
  KAKENHI-PROJECT-16K15711
[Presentation] 子宮頸がんに対する腫瘍溶解性ウイルスと免疫チェックポイント阻害剤療法についての検討2016
- Author(s)
  村上　一行，利部　正裕，川村　花恵，川村　英生，杉山　徹
- Organizer
  第68回日本産科婦人科学会総会・学術講演会
- Place of Presentation
  東京国際フォーラム（東京）
- Year and Date
  2016-04-21
- Data Source
  KAKENHI-PROJECT-16K15711

1. Baba Tsukasa (60508240)

# of Collaborated Projects: 5 results

# of Collaborated Products: 10 results
2. ITAMOCHI Hiroaki (20314601)

# of Collaborated Projects: 4 results

# of Collaborated Products: 2 results
3. 永沢崇幸 (10453309)

# of Collaborated Projects: 3 results

# of Collaborated Products: 6 results
4. 佐藤誠也 (30621007)

# of Collaborated Projects: 2 results

# of Collaborated Products: 1 results
5. 杉山徹 (40162903)

# of Collaborated Projects: 2 results

# of Collaborated Products: 13 results
6. 小島淳美 (60508753)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
7. 庄子忠宏 (00337148)

# of Collaborated Projects: 2 results

# of Collaborated Products: 1 results
8. 大黒多希子 (30767249)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
9. 濱西潤三 (80378736)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
10. 小見英夫 (20382608)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
11. 竹内聡 (60252772)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
12. 吉野直人 (20372881)

# of Collaborated Projects: 1 results

# of Collaborated Products: 12 results
13. 阿保亜紀子 (80326686)

# of Collaborated Projects: 1 results

# of Collaborated Products: 4 results
14. 苫米地英俊 (10771363)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
15. 深川安寿子 (30772511)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
16. 菅井有 (20187628)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
17. 佐藤千絵 (70883726)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
18. 万代昌紀 (80283597)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
19. 山口建 (20378772)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
20. 佐藤翔 (90749863)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
21. 岩谷岳 (70405801)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
22. 遠藤史隆 (70714442)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
23. 千葉洋平 (20892847)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
24. 徳永英樹

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
25. 島田宗昭

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
26. 重田昌吾

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
27. 安彦郁

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
28. 村上隆介

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Kagabu Masahiro 利部 正裕

Research Projects

Research Products

Co-Researchers

Integrating precision medicine for p53abn endometrial cancer

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

卵巣明細胞癌に対するＨＳＦ１経路を標的とした新規治療法の開発

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

子宮癌肉腫に対する免疫逃避改善を誘導するウイルス療法の開発Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of tumor-host integrative therapies to overcome the refractory nature of uterine serous carcinoma

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

The NEFH pathway may be a novel therapeutic target for ovarian clear cell carcinoma

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

The KANK1 pathway may be a novel therapeutic target for ovarian clear cell carcinoma

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of new viral therapy for improvement of immune escape mechanism in ovarian cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] A single-institution retrospective exploratory analysis on the effectiveness and safety of lenvatinib plus pembrolizumab for advanced endometrial cancer: insights from ProMisE molecular classification system2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] SLFN11 is a <i>BRCA</i> Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Ovarian serous borderline tumors with recurrent or extraovarian lesions: a Japanese, retrospective, multi-institutional, population-based study2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] A Phase II Study of S-1 plus Oxaliplatin for Patients with Recurrent Non-Squamous Cell Carcinoma of the Uterine Cervix (Tohoku Gynecologic Cancer Unit: TGCU206 Study)2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Efficacy and Safety of Platinum-based Chemotherapy with Bevacizumab Followed by Bevacizumab Maintenance for Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer During PARP Inhibitor Therapy: A Multicenter Retrospective Study.2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Treatment of HPV-related uterine cervical cancer with a third-generation oncolytic herpes simplex virus in combination with an immune checkpoint inhibitor.2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Comparison of treatment outcomes between first-line chemotherapy with or without bevacizumab for advanced ovarian, fallopian tube, and primary peritoneal cancer (Tohoku gynecologic cancer unit: TGCU-RS001 study)2022

Author(s)

Journal Title

DOI

Kagabu Masahiro 利部正裕

[Journal Article] 腫瘍溶解性ヘルペスウイルスとシクロホスファミドを併用した子宮頸がん新規治療法の検討2017

[Journal Article] 腫瘍溶解性ヘルペスウイルスとシクロホスファミドを併用した子宮頸がん新規治療法の検討2017